CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer

Clinical trial NCT00043394 · COMPLETED

Trial details

NCT number: NCT00043394
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Breast

Start date: 2002-09-01
Primary completion: 2003-10-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.